Navigation Links
NIAID funds studies of how SARS and bird flu evade antiviral responses
Date:10/16/2008

The National Institute of Allergy and Infectious Diseases (NAID), one of the National Institutes of Health, has awarded a contract to the University of Washington (UW) to use systems biology approaches to comprehensively analyze and model the virus-host interactions and cellular response networks that are induced or altered during the course of acute respiratory virus infection.

This new research program will be led by Dr. Michael Katze, UW professor of microbiology and associate director of the Washington National Primate Research Center. Katze will head a multidisciplinary team of researchers from the UW, University of Wisconsin-Madison, University of North Carolina, Oregon Health & Science University, and Pacific Northwest National Laboratory in Richland, Wash.

The team will receive about $17 million over five years for the development of computational models of the host response to H5N1 avian influenza virus ("bird flu") and severe acute respiratory syndrome (SARS) associated coronavirus, two highly pathogenic respiratory viruses that represent significant threats to human health and the global economy. These models will be premised on the acquisition of large datasets through high-throughput genomic, proteomic, and metabolomic technologies, using samples from a variety of biological model systems.

The goal is to generate predictive models that can be experimentally validated in an in vivo setting and which will reveal whether influenza and SARS viruses use common strategies to regulate cellular signaling circuitry and evade antiviral defenses. In addition, these large datasets, as well as the modeled interpretations, will be made freely available to the research community via the Internet, thus providing powerful resources for other scientists exploring viral diseases.

Systems biology provides global views, or models, of the vast numbers of molecular components and interactions that make up complex functions inside living things. The UW research program is unusual in that, in addition to the traditional simple cell culture models, it will also use mouse and nonhuman primate infection models. These animal models will allow researchers to study disease-relevant complexities, Such information is likely to help translate findings into new clinical initiatives, including new targets for therapeutic intervention. Understanding the initial, innate, antiviral response also has potential in developing alternative vaccine strategies, where such early signals are exploited to induce more robust adaptive immune outcomes.

"This program is distinctive in its comparison of different respiratory viruses and the incorporation of animal models," said Katze. "There are few antiviral drugs available and none that work against diverse types of viruses. It would be extremely beneficial to have information that could lead to the rational design of a drug that could be used against a range of different viruses."


'/>"/>

Contact: Leila Gray
leilag@u.washington.edu
206-685-0381
University of Washington
Source:Eurekalert

Related biology news :

1. NIAID announces 25 new awards to develop radiation countermeasures
2. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
3. NIAID announces grants to stimulate food allergy research
4. Human Microbiome Project awards funds for technology development, data analysis and ethical research
5. NSF funds new Center for the Physics of Living Cells at Illinois
6. NSF funds multi-university center to study environmental implications of nanotechnology
7. NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells
8. EPA funds ground-breaking Lyme disease research
9. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
10. W.M. Keck Foundation grant funds reproductive science research
11. National Science Foundation funds research addressing enduring questions of life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the "Nanobiotechnology ... ... separate comprehensive analytics for the US, Japan , ... and forecasts are provided for the period 2015 through 2022. Also, ... and analytics are derived from primary and secondary research. This report ...
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... a better treatment for triple negative breast cancer (TNBC), announced ... France program. The YEi Start in ... to help entrepreneurs grow their business in France ... American companies selected to complete an intensive one week immersion ...
(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
Breaking Biology Technology: